Immunosuppressants: Definition and Risks to Sirolimus & Basiliximab: Clinical Aspects

Content August 26, 2025

Immunosuppressants: Definition and Risks

Immunosuppressants are agents that block lymphocyte activation and proliferation. They reduce acute transplant rejection by suppressing cellular immunity (used as prophylaxis). Frequently combined to achieve greater efficacy with ↓ toxicity. Chronic suppression ↑ risk of infection and malignancy.

T-Cell Activation and Calcineurin Inhibition

#boundingbox

This diagram illustrates the initial steps of T-cell activation, showing how Cyclosporine and Tacrolimus intervene by inhibiting calcineurin.

IL-2 Receptor and Proliferation Pathway Inhibition

#boundingbox

This diagram illustrates the IL-2 receptor pathway and purine synthesis, showing how Sirolimus, Mycophenolate, Azathioprine, Daclizumab, and Basiliximab intervene.

Cyclosporine and Tacrolimus: Details

DRUG	MECHANISM	INDICATIONS	TOXICITY	NOTES
Cyclosporine	Calcineurin inhibitor; binds cyclophilin; Blocks T-cell activation by preventing IL-2 transcription	Psoriasis, rheumatoid arthritis	Nephrotoxicity, hypertension, hyperlipidemia, neurotoxicity, gingival hyperplasia, hirsutism
Tacrolimus (FK506)	Calcineurin inhibitor; binds FK506 binding protein (FKBP); Blocks T-cell activation by preventing IL-2 transcription	Immunosuppression after solid organ transplant	Similar to cyclosporine, ↑ risk of diabetes and neurotoxicity; no gingival hyperplasia or hirsutism	Both calcineurin inhibitors are highly nephrotoxic, especially in higher doses or in patients with ↓ renal function

Sirolimus and Basiliximab: Details

DRUG	MECHANISM	INDICATIONS	TOXICITY	NOTES
Sirolimus (Rapamycin)	mTOR inhibitor; binds FKBP; Blocks T-cell activation and B-cell differentiation by preventing response to IL-2	Kidney transplant rejection prophylaxis specifically Sir Basil’s kidney transplant	“Pansirtopenia” (pancytopenia), insulin resistance, hyperlipidemia; not nephrotoxic	Kidney “sir-vives.” Synergistic with cyclosporine. Also used in drug-eluting stents
Basiliximab	Monoclonal antibody; blocks IL-2R		Edema, hypertension, tremor